Cingulate (CINGW) Free Cash Flow (2021 - 2025)
Cingulate's (CINGW) quarterly Free Cash Flow came in at -$3.8 million in Q4 2025, up 12.26% on a YoY basis from -$3.3 million in Q4 2024, and up 11.56% quarter-over-quarter from -$4.2 million in Q3 2025.
Analysis
Cingulate (CINGW) Free Cash Flow (2021 - 2025) Analysis & Trends
Cingulate (CINGW) has reported Free Cash Flow for 5 consecutive years, with -$3.8 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow rose 12.26% year-over-year to -$3.8 million; the trailing twelve-month figure through Dec 2025 stood at -$17.4 million (up 6.76% YoY), and the FY2025 full-year result was -$17.4 million, up 6.73% from the prior year.
- Free Cash Flow climbed to -$3.8 million in Q4 2025 per CINGW's latest filing, from -$4.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$1.6 million in Q2 2021 and bottomed at -$8.8 million in Q1 2024.
- Historically, Free Cash Flow has averaged -$3.9 million across 5 years, with a median of -$4.1 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow tumbled 180.46% in 2022, then surged 59.14% in 2024.
- Over 5 years, Free Cash Flow stood at -$5.3 million in 2021, then grew by 18.44% to -$4.3 million in 2022, then surged by 36.79% to -$2.7 million in 2023, then plunged by 55.6% to -$4.3 million in 2024, then gained by 12.26% to -$3.8 million in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$3.8 million, -$4.2 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.24 Bn | 625.48 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 441.52 Bn | 434.96 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 365.75 Bn | 358.60 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 266.61 Bn | 258.92 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn | 302.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 3.44 Bn |
| 7 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -389.61 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 495.25 Mn |
| 9 | United Therapeutics | 21.43 Bn | 18.77 Bn | 683.80 Mn | 205.60 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -3.75 Mn |
| Sep 30, 2025 | -4.24 Mn |
| Jun 30, 2025 | -4.80 Mn |
| Mar 31, 2025 | -4.61 Mn |
| Dec 31, 2024 | -4.28 Mn |
| Sep 30, 2024 | -3.68 Mn |
| Jun 30, 2024 | -1.88 Mn |
| Mar 31, 2024 | -8.83 Mn |
| Dec 31, 2023 | -2.75 Mn |
| Sep 30, 2023 | -4.29 Mn |
| Jun 30, 2023 | -4.60 Mn |
| Mar 31, 2023 | -3.61 Mn |
| Dec 31, 2022 | -4.35 Mn |
| Sep 30, 2022 | -3.40 Mn |
| Jun 30, 2022 | -4.41 Mn |
| Mar 31, 2022 | -3.87 Mn |
| Dec 31, 2021 | -5.33 Mn |
| Sep 30, 2021 | -2.60 Mn |
| Jun 30, 2021 | -1.57 Mn |
| Mar 31, 2021 | -1.74 Mn |